A.D.A. v. Johnson & Johnson et al
A.D.A. |
Johnson & Johnson, Janssen Pharmaceuticals, Inc., Noramco, McKinsey & Company, Inc. United States and West Virginia Board of Pharmacy |
5:2022cv00015 |
January 28, 2022 |
US District Court for the Northern District of West Virginia |
John Preston Bailey |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on March 3, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 19 USCA NOTICE OF APPELLATE CASE OPENING: re #17 Notice of Appeal filed by McKinsey & Company, Inc. United States, McKinsey & Company, Inc.. USCA Fourth Circuit USCA Case Number: 22-1219. Case Manager: Anisha Walker (804-916-2704). (nmm) |
Filing 18 Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals re #17 Notice of Appeal (nmm) |
Filing 17 NOTICE OF APPEAL as to #14 Order on Motion to Remand to State Court,, Order on Motion to Stay,,, by McKinsey & Company, Inc. United States. Filing fee $; 505, receipt number AWVNDC-3432341. (George, Keith) |
Filing 16 JPML ORDER VACATING CONDITIONAL TRANSFER ORDER (CTO-22) (( 330 in MDL No. 2996, 6 in WVN/5:22-cv-00015), ( 325 in MDL No. 2996, 1 in WVN/5:22-cv-00015) )IT IS THEREFORE ORDERED that CTO-22 is VACATED insofar as it relates to this action.Signed by Clerk of the Panel John W. Nichols on 2/23/2022. Associated Cases: MDL No. 2996, WVN/5:22-cv-00015. (kac) |
Filing 15 LETTER from Deputy Clerk to Circuit Clerk, Marshall County enclosing copy of #14 ORDER GRANTING PLAINTIFFS' MOTION TO REMAND and certified docket sheet. (nmm) (Additional attachment(s) added on 2/23/2022: #1 Copy of Remand Letter accepted by Marshall County Clerk) (nmm). |
Filing 14 ORDER GRANTING #4 PLAINTIFFS' MOTION TO REMAND. The #8 Joint Motion for an Immediate Stay of All Further Proceedings and Deadlines Pending Transfer of This Action to Multidistrict Litigation is DENIED AS MOOT. The case is hereby REMANDED to the Circuit Court of Marshall County, West Virginia. Signed by District Judge John Preston Bailey on 2/15/2022. (nmm) |
Filing 13 RESPONSE in Opposition re #4 Emergency MOTION to Remand to State Court and to Expedite Resolution of the Motion to Remand filed by Janssen Pharmaceuticals, Inc., Johnson & Johnson, McKinsey & Company, Inc. United States, Noramco. (Williams, Marc) |
Filing 12 REPLY to Response to Motion re #8 Joint MOTION to Stay of All Further Proceedings and Deadlines Pending Transfer of This Action to Multidistrict Litigation filed by Janssen Pharmaceuticals, Inc., Johnson & Johnson, McKinsey & Company, Inc. United States, Noramco. (Attachments: #1 Exhibit Exhibit A, #2 Exhibit Exhibit B)(George, Keith) |
Filing 11 Corporate Disclosure Statement by Janssen Pharmaceuticals, Inc., Johnson & Johnson. (Williams, Marc) |
Filing 10 Corporate Disclosure Statement by Noramco. (Mowen, Kelly) (Main Document 10 replaced on 2/1/2022 to attach non-fillable pdf doc) (nmm). Modified on 2/1/2022; NEF Regenerated (nmm). |
Filing 9 RESPONSE in Opposition re #8 Joint MOTION to Stay of All Further Proceedings and Deadlines Pending Transfer of This Action to Multidistrict Litigation filed by A.D.A.. (Adams, Benjamin) |
Filing 8 Joint MOTION to Stay of All Further Proceedings and Deadlines Pending Transfer of This Action to Multidistrict Litigation by Janssen Pharmaceuticals, Inc., Johnson & Johnson, McKinsey & Company, Inc. United States, Noramco. (Attachments: #1 Exhibit Exhibit 1, #2 Exhibit Exhibit 2)(George, Keith) |
Filing 7 FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING CONFERENCE: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 2/28/2022; Rule 26 Meeting Report due by 3/14/2022; Initial Disclosures due by 3/28/2022. Signed by District Judge John Preston Bailey on 1/31/2022. (nmm) |
Filing 6 STIPULATION Extending Time to Respond to Complaint by Janssen Pharmaceuticals, Inc., Johnson & Johnson, McKinsey & Company, Inc. United States, Noramco. (George, Keith) |
Filing 5 Memorandum in Support re #4 Emergency MOTION to Remand to State Court and to Expedite Resolution of the Motion to Remand filed by A.D.A.. (Attachments: #1 Exhibit A)(Adams, Benjamin) |
Filing 4 Emergency MOTION to Remand to State Court and to Expedite Resolution of the Motion to Remand by A.D.A.. (Adams, Benjamin) |
Filing 3 Corporate Disclosure Statement by McKinsey & Company, Inc. United States identifying Corporate Parent McKinsey & Company, Inc. for McKinsey & Company, Inc. United States.. (George, Keith) Modified docket text re: parent corp name on 1/31/2022; NEF Regenerated (nmm). |
Filing 2 VERIFICATION OF ATTORNEY ADMISSION to Attorneys Charles C. Lifland and David M. Cheifetz (nmm) |
Filing 1 NOTICE OF REMOVAL with State Court Papers from Circuit Court of Marshall County, West Virginia, (case number 21-C-110), filed by Johnson & Johnson, Noramco, McKinsey & Company, Inc. United States, Janssen Pharmaceuticals, Inc. Filing Fee $402. Receipt #AWVNDC-3413876. (Attachments: #1 State Court Docket Sheet, #2 State Court Complaint, #3 Civil Cover Sheet)(nmm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.